About Monalisa Moody

This author has not yet filled in any details.
So far Monalisa Moody has created 14 blog entries.

Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company, Announces Industry Veteran Dr. Simon Pedder has Joined the Board of Directors


Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company, Announces Industry Veteran Dr. Simon Pedder has Joined the Board of Directors 

Seasoned product development

Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company, Announces Industry Veteran Dr. Simon Pedder has Joined the Board of Directors2023-04-14T21:53:02-04:00

Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program


Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program

Targets selected to target a wide range of […]

Voltron Therapeutics, Inc., a Laidlaw Venture Partners Portfolio Company Announces Selection of Therapeutic Targets for Immuno-Oncology Program2023-04-14T21:53:10-04:00

Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”


Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”

Featuring

  • Michael V. Callahan, MD, MSPH, DTM&H (U.K), Massachusetts General Hospital (MGH) Infectious Disease and Director, Clinical Translation and Mass-Casualty Therapeutics at the Vaccine and Immunotherapy Center (VIC)
  • Mark […]
Laidlaw Venture Partners Hosts Panel Discussion “Cutting Edge Perspectives on the Latest Developments in COVID-19 Vaccine Development Strategy”2020-08-25T17:33:39-04:00
Go to Top